BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. (WSE:BML) announced a private placement of 15,000,000 T series shares at a price of PLN 0.1 per share for gross proceeds of PLN 1,500,000 and series D convertible bonds on June 28, 2019. The bonds will are convertible into 15,000,000 series S shares to be issued by December 31, 2019.